Ensuring Access to Lower-Cost Medicines for Seniors Act requires Medicare Part D plans to include generic and biosimilar drugs on their formularies.
The Ensuring Access to Lower-Cost Medicines for Seniors Act amends the Social Security Act to mandate that Medicare Part D prescription drug plans and Medicare Advantage organizations include certain generic drugs and biosimilar biological products on their formularies. Starting from 2028, these plans must include generic drugs and biosimilars in their cost-sharing tiers, ensuring they are not placed at a disadvantage compared to their reference drugs. The bill also prohibits more restrictive access limits on generic and biosimilar drugs compared to their reference drugs.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.